Zydus Lifesciences to acquire Sterling Biotech’s API business for ₹84 crore

In August this year when Zydus acquired a 50% stake in Sterling Biotech Ltd (SBL), the company negotiated for the right to acquire the ‘Target Business’ of SBL at a pre-defined value.

Leave a Reply

Your email address will not be published. Required fields are marked *